Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Head-to-Head Comparison of Fertility-Sparing Approaches to Treat Complex Atypical Hyperplasia of the Edometrium: Megestrol Versus Levonorgestrel-Releasing Intrauterine System (LNG-IUS)

NCT01943058 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.

NCT NCT01943058
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01943058 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Head-to-Head Comparison of Fertility-Sparing Approaches to Treat Complex Atypical Hyperplasia of the Edometrium: Megestrol Versus Levonorgestrel-Releasing Intrauterine System (LNG-IUS)
Lead sponsor
University of Southern California
Phase
Phase 2
Overall status
Withdrawn
Start date
March 31, 2014
Completion date
October 31, 2017
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

atypical endometrial hyperplasia, endometrial adenocarcinoma, recurrent endometrial carcinoma, stage ia endometrial carcinoma, stage ib endometrial carcinoma, stage ii endometrial carcinoma, stage iiia endometrial carcinoma, stage iiib endometrial carcinoma, stage iiic endometrial carcinoma, stage iva endometrial carcinoma, stage ivb endometrial carcinoma